THE DEFINITIVE GUIDE TO MCC950 INHIBITOR

expression, which can be a crucial driver of NIH. In an in vivo mouse design of NIH in vascular grafts, MCC950 significantly enhanced re‐endothelialization and decreased NIH in comparison to PTX or SMS.MCC950, a particular tiny molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. This was suggestiv